More recently, they identified a signature of seven miRNAs termed ePRAM (for “estimated probability of RA by plasma miRNAs”), elevated in RA plasma relative to healthy donors, and allowing RA diagnosis with high specificity and sensitivity, even in ACPA-negative patients [16]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.